CING
Price
$4.66
Change
-$0.00 (-0.00%)
Updated
Oct 22 closing price
Capitalization
67.76M
21 days until earnings call
Intraday BUY SELL Signals
ELVN
Price
$41.93
Change
+$0.11 (+0.26%)
Updated
Oct 22 closing price
Capitalization
3.07B
20 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CING vs ELVN

CING vs ELVN Comparison Chart in %
View a ticker or compare two or three
VS
CING vs. ELVN commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CING is a StrongBuy and ELVN is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for CING with price predictions
Oct 22, 2026

CING sees its Stochastic Oscillator recovers from oversold territory

On October 20, 2026, the Stochastic Oscillator for CING moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 64 instances where the indicator left the oversold zone. In 57 of the 64 cases the stock moved higher in the following days. This puts the odds of a move higher at over 89%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where CING's RSI Oscillator exited the oversold zone, 33 of 38 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 87%.

Following a +6.88% 3-day Advance, the price is estimated to grow further. Considering data from situations where CING advanced for three days, in 191 of 226 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.

CING may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 13, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CING as a result. In 75 of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 88%.

CING moved below its 50-day moving average on September 23, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for CING crossed bearishly below the 50-day moving average on September 28, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 12 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 86%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CING declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for CING entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 60 (best 1 - 100 worst), indicating steady price growth. CING’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 66 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.888) is normal, around the industry mean (2.973). P/E Ratio (-1.309) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (438.009).

The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CING’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for ELVN with price predictions
Oct 22, 2026

ELVN in upward trend: price expected to rise as it breaks its lower Bollinger Band on October 06, 2026

ELVN may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 34 of 37 cases where ELVN's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ELVN's RSI Oscillator exited the oversold zone, 15 of 17 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 88%.

The Momentum Indicator moved above the 0 level on October 21, 2026. You may want to consider a long position or call options on ELVN as a result. In 88 of 105 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 84%.

The Moving Average Convergence Divergence (MACD) for ELVN just turned positive on October 20, 2026. Looking at past instances where ELVN's MACD turned positive, the stock continued to rise in 45 of 56 cases over the following month. The odds of a continued upward trend are 80%.

Following a +1.65% 3-day Advance, the price is estimated to grow further. Considering data from situations where ELVN advanced for three days, in 226 of 276 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ELVN declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 86%.

The Aroon Indicator for ELVN entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 8 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.432) is normal, around the industry mean (2.973). P/E Ratio (-25.412) is within average values for comparable stocks, (-1.705). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (128.121) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (438.009).

The Tickeron PE Growth Rating for this company is 21 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is 55 (best 1 - 100 worst), indicating steady price growth. ELVN’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ELVN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

FUNDAMENTALS RATINGS
ELVN: Fundamental Ratings
ELVN
OUTLOOK RATING
1..100
20
VALUATION
overvalued / fair valued / undervalued
1..100
8
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
94
PRICE GROWTH RATING
1..100
55
P/E GROWTH RATING
1..100
21
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CINGELVN
RSI
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
88%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
89%
Bearish Trend 1 day ago
84%
Momentum
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
84%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
80%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 1 day ago
82%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 9 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
88%
Bearish Trend 1 day ago
90%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (CING: $4.66 vs. ELVN: $41.93)
Brand notoriety: CING and ELVN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CING: 135% vs. ELVN: 111%
Market capitalization -- CING: $67.76M vs. ELVN: $3.07B
CING [@Biotechnology] is valued at $67.76M. ELVN’s [@Biotechnology] market capitalization is $3.07B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $135.64B. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CING’s FA Score shows that 0 FA rating(s) are green while ELVN’s FA Score has 2 green FA rating(s).

  • CING’s FA Score: 0 green, 5 red.
  • ELVN’s FA Score: 2 green, 3 red.
According to our system of comparison, ELVN is a better buy in the long-term than CING.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CING’s TA Score shows that 4 TA indicator(s) are bullish while ELVN’s TA Score has 6 bullish TA indicator(s).

  • CING’s TA Score: 4 bullish, 5 bearish.
  • ELVN’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, ELVN is a better buy in the short-term than CING.

Price Growth

CING (@Biotechnology) experienced а +1.97% price change this week, while ELVN (@Biotechnology) price change was +6.61% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.10%. For the same industry, the average monthly price growth was -18.18%, and the average quarterly price growth was -15.20%.

Reported Earning Dates

CING is expected to report earnings on Nov 12, 2026.

ELVN is expected to report earnings on Nov 11, 2026.

Industries' Descriptions

@Biotechnology (-1.10% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
CING
Daily Signal:
Gain/Loss:
ELVN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

CING and

Correlation & Price change

A.I.dvisor indicates that over the last year, CING has been loosely correlated with CTMX. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if CING jumps, then CTMX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CING
1D Price
Change %
CING100%
N/A
CTMX - CING
33%
Loosely correlated
+1.67%
TBPH - CING
31%
Poorly correlated
N/A
ELVN - CING
29%
Poorly correlated
+0.26%
PLX - CING
28%
Poorly correlated
N/A
TGTX - CING
27%
Poorly correlated
-0.08%
More

ELVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ELVN has been loosely correlated with MLTX. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ELVN jumps, then MLTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELVN
1D Price
Change %
ELVN100%
+0.26%
MLTX - ELVN
43%
Loosely correlated
+15.87%
WVE - ELVN
41%
Loosely correlated
-0.59%
CGON - ELVN
36%
Loosely correlated
+0.48%
CLDX - ELVN
35%
Loosely correlated
-1.36%
ARDX - ELVN
35%
Loosely correlated
+2.24%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FSSL11.850.15
+1.28%
FS Specialty Lending Fund
CPNX11.47N/A
N/A
Tradr 2X Long CPNG Daily ETF (CPNX)
FXA69.55-0.14
-0.20%
Invesco CurrencyShares Australian Dollar Trust (FXA)
HEQT34.42-0.25
-0.72%
Simplify Hedged Equity ETF (HEQT)
GOOP33.06-1.21
-3.53%
Kurv Yield Premium Strategy Google (GOOGL) ETF (GOOP)